Term ends Jan 28, 2031 · High confidence
20-year base term ends Jan 28, 2031
Jan 28, 2011
Jan 28, 2031
Jul 3, 2018
This patent's term is its 20-year base term, with no adjustment for prosecution delay. A terminal disclaimer is resolved from the filed document, and it ends no earlier than this term, so it shortens nothing. 2 of 3 maintenance fees are paid so far. Confidence: High. from the record
How we calculated this date
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Jan 28, 2011, when application 13/016,473, the earliest non-provisional in its chain, was filed (this one was filed Feb 14, 2017) | Jan 28, 2031 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | None on file | no change | High confidence |
| Terminal disclaimer cap | Disclaimer resolved from the filed document (refs US 8,609,707, US 9,034,908, US 9,144,568, US 9,265,831, US 9,572,796, US 9,572,797, US 9,572,887, US 9,579,384, US 9,597,397, US 9,597,399) | resolves to Jan 28, 2031, no earlier than this term, so no change | High confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 2 of 3 maintenance fees paid | In force | High confidence |
| Computed term end | The steps above, in order | Jan 28, 2031 | High confidence |
This family
| US 8,609,707 | In force Jan 2031 | Jan 2031 |
| Application 61/598,729 | Provisional application no patent term | no patent term |
| Application 13/767,672 | Abandoned not computed | not computed |
| US 9,265,831 | In force Jan 2031 | Jan 2031 |
| US 9,572,796 | In force Jan 2031 | Jan 2031 |
| US 9,572,797 | In force Jan 2031 | Jan 2031 |
| US 10,010,533 | this patent Jan 2031 | Jan 2031 |
| Application 16/015,580 | Abandoned not computed | not computed |
Assignments
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Aug 21, 2017 Reel 43346, frame 871 | Eagle Pharmaceuticals, Inc. | JPMorgan Chase Bank, N.A., as Administrative Agent | Security Interest |
| Apr 1, 2025 Reel 70703, frame 524 | JPMorgan Chase Bank, N.A., as Administrative Agent | Eagle Pharmaceuticals, Inc. | Release of Security Interest |
| May 14, 2025 Reel 71275, frame 866 | Eagle Subi LLC, a Delaware Corporation | LSI Financing LLC | Security Interest |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
What's changing
A terminal disclaimer resolved from the filed document, referencing US 8,609,707, US 9,034,908, US 9,144,568, US 9,265,831, US 9,572,796, US 9,572,797, US 9,572,887, US 9,579,384, US 9,597,397, US 9,597,399, ends no earlier than this term, so it caps nothing.